Skip to main content
. 2017 Feb 17;8(11):18337–18347. doi: 10.18632/oncotarget.15440

Table 5. Multivariable linear regression analysis of MEG3 promoter methylation and TET2 expression.

TET2 2-ΔΔCt B P 95% CI
MEG3_1_CpG_10 Control 0.040 0.593 −0.125 0.204
Case −0.152 0.040 −0.296 −0.008
MEG3_1_CpG_24 Control 0.024 0.741 −0.136 0.184
Case −0.119 0.047 −0.236 −0.002
MEG3_2_CpG_2 Control 0.059 0.104 −0.015 0.134
Case −0.091 0.028 −0.171 −0.012
MEG3_5_CpG_11 Control 0.024 0.351 −0.032 0.081
Case −0.057 0.001 −0.084 −0.03
MEG3_6_CpG_1.2.3 Control −0.023 0.213 −0.095 0.049
Case −0.155 0.048 −0.307 −0.002
MEG3_8_CpG_2 Control −0.038 0.509 −0.166 0.089
Case −0.026 0.020 −0.047 −0.005

P < 0.05 indicates statistical significance; 95% CI: 95% confidence interval.